Last update:

HIV & AIDS news

HIV & AIDS

Most at-risk populations for HIV discussing the topic in negative, risky ways get the most social media attention

As the old saying goes, bad news travels fast. Research shows that saying holds true when it comes to young men discussing HIV on social media. An analysis of viral tweets from young men and adolescents, the most at-risk ...

HIV & AIDS

Half of Black gay men will be diagnosed with HIV, despite highly effective preventive treatments—why?

At a pharmacy in Iowa, a 42-year-old Black gay man couldn't find a medication he needed. The pharmacist, a white woman, told him they didn't stock that medication. But while he waited to pay for his other purchases, he saw ...

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Study examines novel drug candidate for treatment of neuroHIV

A recently published article in Experimental Biology and Medicine titled "LM11A-31, a modulator of p75 neurotrophin receptor, suppresses HIV-1 replication and inflammatory response in macrophages" highlights the potential ...

Medical research

A potential new target to treat HIV infection

Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme ...

HIV & AIDS

International migrants left behind in HIV response: Study

International migrants in Australia and beyond are at increased risk of HIV infection due to reduced access to a highly effective prevention measure, a world-first global review led by Monash University has found.

Medical research

PrEP implant that protects against HIV could be near

Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time.

Medications

Second-line switch to dolutegravir noninferior in HIV

For patients with HIV without genotype information, a second-line switch to dolutegravir is noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI), according to a study published in the June 22 issue ...

HIV & AIDS

Meningococcal disease cases up in persons with HIV in 2022

In 2022, there was an increase in meningococcal disease among persons with HIV, with 29 cases reported, accounting for 9.8 percent of all meningococcal disease cases, according to research published in the June 16 issue of ...

HIV & AIDS

Virtual village can empower vulnerable groups of people

New psychosocial stressors and widespread lifestyle changes resulted from the COVID-19 pandemic, contributing to depression, isolation, and anxiety. Many studies have explored the impact of the pandemic on the general population's ...